Genelux (GNLX) Shares Outstanding (2022 - 2026)
Genelux (GNLX) Shares Outstanding (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 44.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.15 Mn |
| Dec 31, 2025 | 37.18 Mn |
| Sep 30, 2025 | 37.89 Mn |
| Jun 30, 2025 | 37.95 Mn |
| Mar 31, 2025 | 34.93 Mn |
| Dec 31, 2024 | 31.45 Mn |
| Sep 30, 2024 | 34.53 Mn |
| Jun 30, 2024 | 29.69 Mn |
| Mar 31, 2024 | 26.85 Mn |
| Dec 31, 2023 | 24.43 Mn |
| Sep 30, 2023 | 26.21 Mn |
| Jun 30, 2023 | 25.07 Mn |
| Mar 31, 2023 | 19.58 Mn |
| Dec 31, 2022 | 9.12 Mn |
| Sep 30, 2022 | 9.12 Mn |
| Mar 31, 2022 | 9.11 Mn |